Page last updated: 2024-11-04

ropinirole and Neuroblastoma

ropinirole has been researched along with Neuroblastoma in 2 studies

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
"Ropinirole (ROP) is a dopamine agonist that has been used as therapy for Parkinson's disease."1.43Ropinirole alters gene expression profiles in SH-SY5Y cells: a whole genome microarray study. ( Jin, G; Le, WD; Zhu, MZ, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, MZ1
Le, WD1
Jin, G1
Pan, T1
Le, W1
Jankovic, J1

Other Studies

2 other studies available for ropinirole and Neuroblastoma

ArticleYear
Ropinirole alters gene expression profiles in SH-SY5Y cells: a whole genome microarray study.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2016, Volume: 49, Issue:2

    Topics: Antiparkinson Agents; Blotting, Western; Cell Line, Tumor; Chromosomes, Human, Pair 1; Class II Phos

2016
Slowing Parkinson's disease progression: recent dopamine agonist trials.
    Neurology, 2004, Jan-27, Volume: 62, Issue:2

    Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Top

2004